Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin Type

  • Agustin Alomar
  • , Eggert Stockfleth
  • , Thomas Dirschka
  • , Girish Gupta
  • , Selim Aractingi
  • , Rada Dakovic
  • , Ketty Peris
  • USP Institut Universitari Dexeus
  • Ruhr University Bochum
  • Dermatological Practice Centre
  • Monklands Hospital
  • Université Paris Cité
  • MEDA Pharma GmbH and Co. KG

Research output: Contribution to journal › Article

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin Type'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry